Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 25% Cheaper
Unfortunately for some shareholders, the Cue Health Inc. (NASDAQ:HLTH) share price has dived 25% in the last thirty days, prolonging recent pain. The recent drop completes a disastrous twelve month
Cue Health to Cut About Half of Workforce
By Ben Glickman Cue Health said on Wednesday it would cut about half of its workforce as it looks to reduce costs and focus on its core technology offering, marking its second round of layoffs this y
Cue Health to Announce First Quarter Financial Results
SAN DIEGO--(BUSINESS WIRE)--Apr. 29, 2024-- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Mo
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
Cue Health Disclosed It Has Been Undertaking Comprehensive Review Of Strategic Alternative; Strategic Review Process To Evaluate Options Including Potential Sale
Cue Health Disclosed It Has Been Undertaking Comprehensive Review Of Strategic Alternative; Strategic Review Process To Evaluate Options Including Potential Sale
12 Health Care Stocks Moving In Monday's After-Market Session
GainersKineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million. Moleculin Biotech (NASDAQ:MBRX) stoc
Cue Health Finalizes Separation Terms With Ex-Officer Khattak
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kezar Life Sciences (KZR), Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Cue Health (HLTH)
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
To the annoyance of some shareholders, Cue Health Inc. (NASDAQ:HLTH) shares are down a considerable 26% in the last month, which continues a horrid run for the company. For any long-term shareholde
Cue Health's Hold Rating Amidst Leadership Changes and FDA Setbacks
Cue Health Announces Major Leadership Restructuring
Cue Health Reveals Strategic Actions; Names Clint Sever As CEO; Seeks To Refine And Strengthen Its Overarching Strategy And Cost Structure
Clint Sever, co-founder and current Chief Product Officer, has been appointed CEO, effective immediately. Sever succeeds Ayub Khattak, who is stepping down as Chief Executive Officer, President, and C
Cue Health: Khattak to Resign as Chairman, Remain on Board >HLTH
Cue Health: Khattak to Resign as Chairman, Remain on Board >HLTH
Cue Health: Comprehensive Review of Business, Operations to Be Initiated >HLTH
Cue Health: Comprehensive Review of Business, Operations to Be Initiated >HLTH
Cue Health Names Clint Sever as CEO >HLTH
Cue Health Names Clint Sever as CEO >HLTH
Cue Health: Sever Succeeds Ayub Khattak >HLTH
Cue Health: Sever Succeeds Ayub Khattak >HLTH
Cue Health Announces Strategic Actions to Position Company for Next Stage
Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the "Board") to best position the Company for its next stage
12 Health Care Stocks Moving In Friday's After-Market Session
GainersCue Health (NASDAQ:HLTH) shares increased by 12.1% to $0.22 during Friday's after-market session. The company's market cap stands at $34.8 million. As per the press release, Q4 earnings came ou
Cue Health Inc. (NASDAQ:HLTH) Q4 2023 Earnings Call Transcript
Earnings Call: Cue Health Beats Q4 Revenue, Plans Test Expansion
No Data